Press publications

QLi5 Therapeutics Attracts EUR 10 Million in Series A Financing

Read Article

Qurient sets up joint firm with Nobel chemistry prize winner

Read Article

Launch of Start-up QLi5 Therapeutics

Read Article

About Us

Next Generation Proteasome inhibitors for unmet medical needs by an international Research & Development Network

Contact

  • QLi5 Therapeutics GmbH
    Otto-Hahn-Straße 15
    D – 44227 Dortmund
  • huber@QLi5tx.com